AT294863T - Novel vegf-similar factors - Google Patents

Novel vegf-similar factors

Info

Publication number
AT294863T
AT294863T AT97930804T AT97930804T AT294863T AT 294863 T AT294863 T AT 294863T AT 97930804 T AT97930804 T AT 97930804T AT 97930804 T AT97930804 T AT 97930804T AT 294863 T AT294863 T AT 294863T
Authority
AT
Austria
Prior art keywords
similar factors
novel vegf
vegf
novel
factors
Prior art date
Application number
AT97930804T
Other languages
German (de)
Inventor
Yuichi Hirata
Junichi Nezu
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to JP18521696 priority Critical
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to PCT/JP1997/002456 priority patent/WO1998002543A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16166915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT294863(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of AT294863T publication Critical patent/AT294863T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AT97930804T 1996-07-15 1997-07-15 Novel vegf-similar factors AT294863T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP18521696 1996-07-15
PCT/JP1997/002456 WO1998002543A1 (en) 1996-07-15 1997-07-15 Novel vegf-like factors

Publications (1)

Publication Number Publication Date
AT294863T true AT294863T (en) 2005-05-15

Family

ID=16166915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930804T AT294863T (en) 1996-07-15 1997-07-15 Novel vegf-similar factors

Country Status (8)

Country Link
US (4) US6828426B1 (en)
EP (1) EP0935001B2 (en)
JP (1) JP3911028B2 (en)
AT (1) AT294863T (en)
AU (1) AU733322B2 (en)
DE (1) DE69733204T3 (en)
ES (1) ES2242227T5 (en)
WO (1) WO1998002543A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4669984B2 (en) 2001-01-19 2011-04-13 ベジェニクス リミテッド F1t4 (VEGFR-3) and antitumor therapy as a target for tumor imaging
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US6818220B1 (en) 1994-11-14 2004-11-16 Licentia Ltd. Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
US7727761B2 (en) 1995-08-01 2010-06-01 Vegenics Limited Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
US6361946B1 (en) 1997-02-05 2002-03-26 Licentia Ltd Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
US7125714B2 (en) 1997-02-05 2006-10-24 Licentia Ltd. Progenitor cell materials and methods
AT242809T (en) * 1995-09-08 2003-06-15 Genentech Inc Vegf related protein
EP1553182B1 (en) * 1995-09-29 2010-03-03 Universita Degli Studi Di Siena Regulated genes and uses thereof
US7357927B2 (en) 1996-03-12 2008-04-15 Human Genome Sciences, Inc. Death domain containing receptors
US6713061B1 (en) 1996-03-12 2004-03-30 Human Genome Sciences, Inc. Death domain containing receptors
WO1997033904A1 (en) 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Death domain containing receptors
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1998002543A1 (en) 1996-07-15 1998-01-22 Chugai Research Institute For Molecular Medicine, Inc. Novel vegf-like factors
AT306546T (en) * 1996-08-23 2005-10-15 Ludwig Inst Cancer Res Recombinant vascular endothelial cell growth factor d (vegf-d)
CN1345247A (en) * 1997-12-24 2002-04-17 路德维格癌症研究所 Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas
US6958147B1 (en) * 1998-10-26 2005-10-25 Licentia Ltd Use of VEGF-C to prevent restenosis
US6383484B1 (en) * 1998-12-21 2002-05-07 Ludwig Institute For Cancer Research Antibodies to truncated VEGF-D and thereof
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
CA2363779A1 (en) 1999-02-26 2000-08-31 Human Genome Sciences, Inc. Human endokine alpha and methods of use
US6764820B2 (en) * 1999-03-26 2004-07-20 Ludwig Institute For Cancer Research Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
AU3988401A (en) 2000-02-25 2001-09-03 Ludwig Inst Cancer Res Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins
US20020102260A1 (en) 2000-03-02 2002-08-01 Marc Achen Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
AU2006201128B2 (en) * 2000-03-02 2009-05-28 Vegenics Limited Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor D
DK1259248T3 (en) * 2000-03-02 2005-04-11 Ludwig Inst Cancer Res Method of treating cancers expressing vascular endothelial growth factor D
ES2234818T3 (en) * 2000-03-02 2005-07-01 Ludwig Institute For Cancer Research PROCEDURE TO TREAT CANCERES THAT EXPRESS THE ENDOTELIAL GROWTH FACTOR D.
EP2295456A1 (en) 2000-04-12 2011-03-16 Human Genome Sciences, Inc. Albumin fusion proteins
WO2001082870A2 (en) * 2000-05-03 2001-11-08 Ludwig Institute For Cancer Research A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
US20040132675A1 (en) * 2002-02-08 2004-07-08 Calvin Kuo Method for treating cancer and increasing hematocrit levels
DK1463751T3 (en) 2001-12-21 2013-08-26 Human Genome Sciences Inc Albumin Fusion Proteins.
US7563882B2 (en) 2002-06-10 2009-07-21 University Of Rochester Polynucleotides encoding antibodies that bind to the C35 polypeptide
WO2005087177A2 (en) 2004-03-05 2005-09-22 Ludwig Institute For Cancer Research Chimeric anti-vegf-d antibodies and humanized anti-vegf-d antibodies and methods of using same
WO2007022287A2 (en) 2005-08-15 2007-02-22 Vegenics Limited Modified vegf and pdgf with improved angiogenic properties
WO2009082485A1 (en) 2007-12-26 2009-07-02 Vaccinex, Inc. Anti-c35 antibody combination therapies and methods
US20100029491A1 (en) * 2008-07-11 2010-02-04 Maike Schmidt Methods and compositions for diagnostic use for tumor treatment
WO2011056494A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
WO2011154308A1 (en) 2010-06-08 2011-12-15 Proyecto De Biomedicina Cima, S.L. New compositions and cell therapy methods for the treatment of cirrhosis
SG11201505940WA (en) 2013-02-18 2015-08-28 Vegenics Pty Ltd Ligand binding molecules and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666868B2 (en) 1992-10-28 2006-06-14 Genentech, Inc. Use of anti-VEGF antibodies for the treatment of cancer
CN1701814A (en) 1992-11-13 2005-11-30 马克斯普朗克科学促进协会 F1K-1 is a receptor for vascular endothelial growth factor
EP0694042B1 (en) 1993-03-25 2004-11-03 Merck & Co., Inc. Inhibitor of vascular endothelial cell growth factor
PL181783B1 (en) 1993-09-03 2001-09-28 Chugai Pharmaceutical Co Ltd Monoclonal antibodies having properties making them able to cause apoptosis
AU696764B2 (en) 1994-03-08 1998-09-17 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US6645933B1 (en) 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
AT242809T (en) 1995-09-08 2003-06-15 Genentech Inc Vegf related protein
EP1553182B1 (en) 1995-09-29 2010-03-03 Universita Degli Studi Di Siena Regulated genes and uses thereof
WO1998002543A1 (en) 1996-07-15 1998-01-22 Chugai Research Institute For Molecular Medicine, Inc. Novel vegf-like factors
AT306546T (en) 1996-08-23 2005-10-15 Ludwig Inst Cancer Res Recombinant vascular endothelial cell growth factor d (vegf-d)
WO1998024811A2 (en) * 1996-12-06 1998-06-11 Zymogenetics, Inc. Vascular endothelial growth factor

Also Published As

Publication number Publication date
US20050112665A1 (en) 2005-05-26
EP0935001B9 (en) 2007-01-24
EP0935001B1 (en) 2005-05-04
JP3911028B2 (en) 2007-05-09
ES2242227T5 (en) 2011-12-09
WO1998002543A1 (en) 1998-01-22
EP0935001A4 (en) 2000-08-23
AU733322B2 (en) 2001-05-10
US7803576B2 (en) 2010-09-28
US6828426B1 (en) 2004-12-07
ES2242227T3 (en) 2005-11-01
EP0935001A1 (en) 1999-08-11
AU3461097A (en) 1998-02-09
EP0935001B2 (en) 2011-08-10
DE69733204T3 (en) 2012-03-08
DE69733204D1 (en) 2005-06-09
US20060172343A1 (en) 2006-08-03
US20110293602A1 (en) 2011-12-01
DE69733204T2 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
DK1361751T3 (en) Internettelevisionsprogramquidesystem
DK0886535T3 (en) Radiofrekvensdilatorkappe
DK0901474T3 (en) Arylpyrimidinderivater
DK0909430T3 (en) Tilstandsanalysator
DK1344524T3 (en) Refluksinhibitorer
DK0918505T3 (en) Hudtoningsformulering
DK0966435T3 (en) Aminoindanderivater
DK0791344T3 (en) Knæledsendoprotese
DK0958018T3 (en) Legetöjsbyggesætsystem
DK0815946T3 (en) Mediedispenser
DK0948486T3 (en) Pesticide-1-arylpyrazoles
DK1852678T3 (en) Laserlysreferenceværktöj
DK0948716T3 (en) Havbölgeenergiekstraktion
DK0984778T3 (en) Neuropeptide-Y-ligands
DK0841545T3 (en) Hvirvelstrømsdetektor
DK0882051T3 (en) Thiophenopyrimidiner
DK200400102U4 (en) Börnesikringsgitter
AT243607T (en) Rasiesystem
AT369165T (en) Abgabevorrichting
DK0825223T3 (en) Sanitærbeholder
AT307672T (en) Reaktionsgefaesse
AT211157T (en) Polylaktidfilme
AT226370T (en) Kabelverschraubung
AT230468T (en) Verschlusskappe
AT219441T (en) Multibay steige

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties